Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma — StellaEarly Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(4 sites)
Canada
BCCA - Vancouver, Vancouver, British Columbia Kingston Health Sciences Centre, Kingston, Ontario University Health Network, Toronto, Ontario The Jewish General Hospital, Montreal, Quebec Last updated February 2026